LED Medical Diagnostics Inc. reported audited consolidated earnings results for the fourth quarter and full year ended December 31, 2017. For the quarter, the company reported revenues were USD 3.7 million, which was an increase of 98% over the same period in the prior year and 16% over the immediately preceding quarter. Net loss was USD 0.8 million compared to a net loss of USD 1.4 million for the three months ended December 31, 2016. For the year, the company reported revenue was USD 12.7 million with gross margin of 56% compared to revenue in fiscal 2016 of USD 10.2 million with gross margin of 24%. EBITDA in 2017 from operations, net of acquisition costs, was USD 1.3 million compared to EBITDA of USD 4.5 million in 2016. EBITDA included a USD 365,000 non-cash expense related to the Apteryx acquisition recorded in the fourth quarter. Net loss was USD 2.4 million compared to USD 5.3 million for the year ended December 31, 2016. The decrease in net loss is mainly attributable to higher margin Apteryx software products.